Muhammad Nadeem Alvi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Muhammad Nadeem Alvi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Huma Hameed
Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, Pakistan
2 shared publications - Imtiaz Majeed
Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, Pakistan
2 shared publications - Mahtab Ahmad Khan
Faculty of Pharmaceutical Sciences, University of Central Punjab (UCP), Lahore, Pakistan
2 shared publications - Muhammad Zaman
Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan
2 shared publications - Ahmad Salawi
Department of Pharmaceutics, College of Pharmacy, Jazan University
1 shared publication - Imama Khan
Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore, Pakistan
1 shared publication
Latest Publications
- 8 April 2025
- Published by Springer Nature in Polymer Bulletin
- Vol. 82 (11) , 5241-5274
Chitosan as a multifunctional polymer in drug delivery systems for diabetic wound management
- 8 April 2025
- Published by Springer Nature in Polymer Bulletin
- Vol. 82 (11) , 5241-5274
Chitosan as a multifunctional polymer in drug delivery systems for diabetic wound management
- 18 December 2024
- Published by Springer Nature in BioNanoScience
- Vol. 15 (1) , 1-29
Unlocking the Power of Antioxidant Nanoparticles: Insights into Classification, Formulation, Characterization, and Biomedical Applications
- 18 December 2024
- Published by Springer Nature in BioNanoScience
- Vol. 15 (1) , 1-29
Unlocking the Power of Antioxidant Nanoparticles: Insights into Classification, Formulation, Characterization, and Biomedical Applications
- Open Access
Synthesis of Chemically Cross-Linked pH-Sensitive Hydrogels for the Sustained Delivery of Ezetimibe
In recent years, pH-sensitive hydrogels have been developed for the delivery of therapeutic agents to specific target sites that have a defined pH range. The use of pH-responsive polymers in hydrogels allows drug delivery to the desired pH range of the target organ. The primary aim is to increase the retention time of the drug in the small intestine by utilizing the swelling mechanism of the hydrogel at intestinal pH. In this study, polyethylene glycol (PEG) was used as a polymer to formulate a pH-sensitive hydrogel of Ezetimibe to deliver the drug to the small intestine where it inhibits the absorption of cholesterol. Design Expert software was applied to design and optimize the trial formulations in order to obtain an optimized formulation that has all the desired characteristics of the hydrogels. The PEG/Acrylic Acid hydrogels showed the maximum swelling at pH 6.8, which is consistent with the pH of the small intestine (pH 6–7.4). The maximum entrapment efficiency of the hydrogels was 99%. The hydrogel released 80–90% of the drug within 24 h and followed first-order release kinetics, which showed that the release from the drug was sustained. Hence, the results showed that the choice of a suitable polymer can lead to the development of an efficient drug-loaded hydrogel that can deliver the drug at the specific pH of the target organ.
Open AccessSynthesis of Chemically Cross-Linked pH-Sensitive Hydrogels for the Sustained Delivery of Ezetimibe
In recent years, pH-sensitive hydrogels have been developed for the delivery of therapeutic agents to specific target sites that have a defined pH range. The use of pH-responsive polymers in hydrogels allows drug delivery to the desired pH range of the target organ. The primary aim is to increase the retention time of the drug in the small intestine by utilizing the swelling mechanism of the hydrogel at intestinal pH. In this study, polyethylene glycol (PEG) was used as a polymer to formulate a pH-sensitive hydrogel of Ezetimibe to deliver the drug to the small intestine where it inhibits the absorption of cholesterol. Design Expert software was applied to design and optimize the trial formulations in order to obtain an optimized formulation that has all the desired characteristics of the hydrogels. The PEG/Acrylic Acid hydrogels showed the maximum swelling at pH 6.8, which is consistent with the pH of the small intestine (pH 6–7.4). The maximum entrapment efficiency of the hydrogels was 99%. The hydrogel released 80–90% of the drug within 24 h and followed first-order release kinetics, which showed that the release from the drug was sustained. Hence, the results showed that the choice of a suitable polymer can lead to the development of an efficient drug-loaded hydrogel that can deliver the drug at the specific pH of the target organ.